126 related articles for article (PubMed ID: 18706819)
1. Molecular modeling and dynamics studies of Shikimate Kinase from Bacillus anthracis.
Pauli I; Caceres RA; de Azevedo WF
Bioorg Med Chem; 2008 Sep; 16(17):8098-108. PubMed ID: 18706819
[TBL] [Abstract][Full Text] [Related]
2. Structural studies of shikimate dehydrogenase from Bacillus anthracis complexed with cofactor NADP.
Barcellos GB; Caceres RA; de Azevedo WF
J Mol Model; 2009 Feb; 15(2):147-55. PubMed ID: 19043750
[TBL] [Abstract][Full Text] [Related]
3. Structure of shikimate kinase from Mycobacterium tuberculosis reveals the binding of shikimic acid.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; Santos DS; de Azevedo WF
Acta Crystallogr D Biol Crystallogr; 2004 Dec; 60(Pt 12 Pt 2):2310-9. PubMed ID: 15583379
[TBL] [Abstract][Full Text] [Related]
4. Molecular model of shikimate kinase from Mycobacterium tuberculosis.
Filgueira de Azevedo W; Canduri F; Simões de Oliveira J; Basso LA; Palma MS; Pereira JH; Santos DS
Biochem Biophys Res Commun; 2002 Jul; 295(1):142-8. PubMed ID: 12083781
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of shikimate kinase from Mycobacterium tuberculosis reveals the dynamic role of the LID domain in catalysis.
Gu Y; Reshetnikova L; Li Y; Wu Y; Yan H; Singh S; Ji X
J Mol Biol; 2002 Jun; 319(3):779-89. PubMed ID: 12054870
[TBL] [Abstract][Full Text] [Related]
6. Discovery of Helicobacter pylori shikimate kinase inhibitors: bioassay and molecular modeling.
Han C; Zhang J; Chen L; Chen K; Shen X; Jiang H
Bioorg Med Chem; 2007 Jan; 15(2):656-62. PubMed ID: 17098431
[TBL] [Abstract][Full Text] [Related]
7. The three-dimensional structure of shikimate kinase.
Krell T; Coggins JR; Lapthorn AJ
J Mol Biol; 1998 May; 278(5):983-97. PubMed ID: 9600856
[TBL] [Abstract][Full Text] [Related]
8. Crystallographic studies of shikimate binding and induced conformational changes in Mycobacterium tuberculosis shikimate kinase.
Dhaliwal B; Nichols CE; Ren J; Lockyer M; Charles I; Hawkins AR; Stammers DK
FEBS Lett; 2004 Sep; 574(1-3):49-54. PubMed ID: 15358538
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of phosphoryl transfer catalyzed by shikimate kinase from Mycobacterium tuberculosis.
Hartmann MD; Bourenkov GP; Oberschall A; Strizhov N; Bartunik HD
J Mol Biol; 2006 Dec; 364(3):411-23. PubMed ID: 17020768
[TBL] [Abstract][Full Text] [Related]
10. Molecular modeling, dynamics and docking studies of purine nucleoside phosphorylase from Streptococcus pyogenes.
Timmers LF; Caceres RA; Dias R; Basso LA; Santos DS; de Azevedo WF
Biophys Chem; 2009 Jun; 142(1-3):7-16. PubMed ID: 19282092
[TBL] [Abstract][Full Text] [Related]
11. Structure-based in silico design of a high-affinity dipeptide inhibitor for novel protein drug target Shikimate kinase of Mycobacterium tuberculosis.
Kumar M; Verma S; Sharma S; Srinivasan A; Singh TP; Kaur P
Chem Biol Drug Des; 2010 Sep; 76(3):277-84. PubMed ID: 20626408
[TBL] [Abstract][Full Text] [Related]
12. Interaction of shikimic acid with shikimate kinase.
Pereira JH; de Oliveira JS; Canduri F; Dias MV; Palma MS; Basso LA; de Azevedo WF; Santos DS
Biochem Biophys Res Commun; 2004 Dec; 325(1):10-7. PubMed ID: 15522194
[TBL] [Abstract][Full Text] [Related]
13. Shikimate kinase, a protein target for drug design.
Coracini JD; de Azevedo WF
Curr Med Chem; 2014; 21(5):592-604. PubMed ID: 24164195
[TBL] [Abstract][Full Text] [Related]
14. Structural studies of thymidine kinases from Bacillus anthracis and Bacillus cereus provide insights into quaternary structure and conformational changes upon substrate binding.
Kosinska U; Carnrot C; Sandrini MP; Clausen AR; Wang L; Piskur J; Eriksson S; Eklund H
FEBS J; 2007 Feb; 274(3):727-37. PubMed ID: 17288553
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and dynamics simulations of PNP from Streptococcus agalactiae.
Caceres RA; Saraiva Timmers LF; Dias R; Basso LA; Santos DS; de Azevedo WF
Bioorg Med Chem; 2008 May; 16(9):4984-93. PubMed ID: 18381241
[TBL] [Abstract][Full Text] [Related]
16. Structural studies of shikimate 5-dehydrogenase from Mycobacterium tuberculosis.
Arcuri HA; Borges JC; Fonseca IO; Pereira JH; Neto JR; Basso LA; Santos DS; de Azevedo WF
Proteins; 2008 Aug; 72(2):720-30. PubMed ID: 18260104
[TBL] [Abstract][Full Text] [Related]
17. Cloning, expression, and characterization of recombinant nitric oxide synthase-like protein from Bacillus anthracis.
Midha S; Mishra R; Aziz MA; Sharma M; Mishra A; Khandelwal P; Bhatnagar R
Biochem Biophys Res Commun; 2005 Oct; 336(1):346-56. PubMed ID: 16150307
[TBL] [Abstract][Full Text] [Related]
18. Structural basis for shikimate-binding specificity of Helicobacter pylori shikimate kinase.
Cheng WC; Chang YN; Wang WC
J Bacteriol; 2005 Dec; 187(23):8156-63. PubMed ID: 16291688
[TBL] [Abstract][Full Text] [Related]
19. Shikimate kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: kinetics and structural dynamics of a potential molecular target for drug development.
Saidemberg DM; Passarelli AW; Rodrigues AV; Basso LA; Santos DS; Palma MS
Curr Med Chem; 2011; 18(9):1299-310. PubMed ID: 21366533
[TBL] [Abstract][Full Text] [Related]
20. Crystal structure of the anthrax drug target, Bacillus anthracis dihydrofolate reductase.
Bennett BC; Xu H; Simmerman RF; Lee RE; Dealwis CG
J Med Chem; 2007 Sep; 50(18):4374-81. PubMed ID: 17696333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
